PPD‘s (NYSE:PPDI) new CEO Ray Hill doesn’t come from a clinical research organization, but his experience fits with where the CRO industry is going. IMS Health provides data and research for pharmaceutical companies and others in the health space. As a provider of research and services to pharma companies, IMS’ work is not far off […]
PPD‘s (NYSE:PPDI) new CEO brings the clinical research organization a long track record in healthcare and life sciences consulting. Raymond Hill comes to Wilmington, North Carolina-based PPD from research and consulting firm IMS Health, where he has worked for the past eight years. His appointment as PPD CEO and member of the CRO’s board of […]
A new report by Paubox calls for healthcare IT leaders to dispose of outdated assumptions about email security and address the challenges of evolving cybersecurity threats.
Clinical research organization PPD (NYSE:PPDI) has appointed a chief scientific officer for BioDuro, its drug discovery subsidiary in China. Jasmine Cui brings to PPD more than 15 years of drug discovery experience, including 14 years at Merck (NYSE:MRK). Wilmington, North Carolina-based PPD has made China a big part of its business through acquisitions. In 2009, […]
Clinical research organization PPD (NYSE:PPDI) is talking with private equity firm The Carlyle Group about an M&A deal. Bloomberg News reports that Carlyle is in exclusive talks to possibly acquire Wilmington, North Carolina-based PPD, which is the third-largest CRO in the industry with more than $1.4 billion in 2010 revenue. Bloomberg cited five unnamed sources […]
PPD (NYSE:PPDI) released second-quarter earnings today and in the conference call to follow Wednesday morning, I would bet on at least two questions analysts will pose to management of the North Carolina clinical research organization: How is the search progressing for a new CEO to replace retired CEO David Grange? Is PPD in talks with […]
Talk of whether PPD (NYSE:PPDI) is for sale has prompted the clinical research organization to publicly state it not in talks with any other CRO regarding a merger or acquisition. But Wilmington, North Carolina-based PPD did say that its board of directors has asked management to review the company’s strategic plan and capital structure “with […]
The home care industry is booming. As Baby Boomers age and more families seek in-home solutions for loved ones, demand for home care services is at an all-time high.
Shares of North Carolina clinical research organization PPD (NYSE:PPDI) climbed on reports that the company is for sale. PPD shares are trading at $32.35 on Monday morning, up more than 16 percent over Friday’s close. Shares later leveled off at $30.92 cents per share. The Wall Street Journal cited unnamed “people familiar with the matter” […]
PPD (NYSE:PPDI) is expanding its consulting services into four new areas, signaling the kinds of services that the Wilmington, North Carolina clinical research organization believes will be growth opportunities. The CRO’s consulting arm, PPD Consulting, has added biosimilars, adaptive trial design, China regulatory strategy and cardiovascular outcome studies as four new practice areas for the […]
A North Carolina CRO stands atop the rankings of a major industry survey and it’s not Quintiles. PPD (NYSE:PPDI), based in Wilmington, North Carolina, is the top-rated global clinical research organization in the 2011 CenterWatch Global Investigative Site Survey. The results are based on survey responses from clinical research site professionals in more than 70 […]
PPD‘s net income soared to $37.3 million in the first quarter, more than double the profits the clinical research organization reported a year ago, as the Wilmington, North Carolina-based company continued to report strong growth providing clinical trial services to pharmaceutical companies. First-quarter net revenue for PPD (NASDAQ:PPDI) was $383.2 million, a more than 10 […]
Explore top PTSD treatment centers in Arizona, offering personalized care, holistic therapies and expert support to help individuals heal and reclaim their lives.
PPD, a clinical research organization based in Wilmington, North Carolina, announced that CEO David Grange will retire in May. The company's board is already planning a search for a successor and will look for internal candidates as well as external candidates.
Layoffs reports at the clinical research organization Quintiles are not an immediate cause for alarm. But it's worth noting that other CROs have also laid off workers, cuts focused primarily in North America. Cuts at Quintiles could be an indicator that the industry's largest CRO is feeling the same pressures.